---
document_datetime: 2023-09-21 22:00:26
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cinqaero-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: cinqaero-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 7.3538808
conversion_datetime: 2025-12-25 06:01:33.868074
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cinqaero

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                      | Opinion/ Notification 0F 1 issued on   | Commission Decision Issued 1F 2 / amended on   | Product Information affected 2F 3   | Summary                                                                                                                                                                                                                              |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|------------------------------------------------|-------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0048              | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - medicinal product in accordance with an approved stability protocol | 26/05/2023                             |                                                | SmPC                                | Product information section 6.3 is updated to reflect the shelf-life extension of the finished product CINQAERO 10 mg/mL concentrate for solution for infusion as packaged for sale from 3 years to 4 years when stored at 2 - 8 Â°C. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0047/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 03/05/2023   | n/a   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0046     | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 12/12/2022   | n/a   |
| IB/0045/G   | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.2.d - Change in test procedure for the finished | 03/11/2022   | n/a   |

<div style=\"page-break-after: always\"></div>

|                     | product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                 |            |     |    |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|-----------------------------------|
| IB/0044             | B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation                                                                                                                                                                                                                                                         | 13/09/2022 | n/a |    |                                   |
| IB/0043             | B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation                                                                                                                                                                                                                                                         | 05/04/2022 | n/a |    |                                   |
| IB/0042/G           | This was an application for a group of variations. B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with | 06/01/2022 | n/a |    |                                   |
| IB/0041             | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                            | 07/12/2021 | n/a |    |                                   |
| N/0040              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                | 08/10/2021 |     | PL |                                   |
| PSUSA/10523 /202102 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                                        | 30/09/2021 | n/a |    | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| R/0038              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                               | 25/03/2021   | 01/06/2021   | SmPC and PL   | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Cinqaero in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0037/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch control/testing takes place and any of the test method at the site is a biol/immunol method | 19/11/2020   | n/a          |               |                                                                                                                                                                                                                                                                          |
| PSUSA/10523 /202002 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                                                                                                              | 01/10/2020   | n/a          |               | PRAC Recommendation - maintenance                                                                                                                                                                                                                                        |
| IB/0036             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                | 17/09/2020   | n/a          |               |                                                                                                                                                                                                                                                                          |
| IB/0035             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                      | 01/09/2020   | n/a          |               |                                                                                                                                                                                                                                                                          |
| IB/0034             | B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of                                                                                                                                                                                                                                                                            | 21/07/2020   | n/a          |               |                                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|           | a Member State - Excipient/AS starting material                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |     |           |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IB/0033   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 13/07/2020 | n/a | of the AS |
| IA/0032   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 25/05/2020 | n/a |           |
| IB/0030/G | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of | 21/04/2020 | n/a |           |

<div style=\"page-break-after: always\"></div>

|                     | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                          |            |            |                       |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-----------------------------------|
| IA/0029             | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                                                                                                             | 26/03/2020 | n/a        |                       |                                   |
| IB/0028/G           | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) | 11/03/2020 | n/a        |                       |                                   |
| IA/0027             | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                                                                             | 22/11/2019 | 05/11/2020 | SmPC, Annex II and PL |                                   |
| PSUSA/10523 /201902 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                                                                               | 05/09/2019 | n/a        |                       | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IB/0025             | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                             | 16/04/2019   | n/a        |                 |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-----------------------------------|
| IA/0024             | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                                               | 29/03/2019   | n/a        |                 |                                   |
| PSUSA/10523 /201808 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                 | 14/03/2019   | n/a        |                 | PRAC Recommendation - maintenance |
| IAIN/0023           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                   | 10/01/2019   | 10/12/2019 | Annex II and PL |                                   |
| IB/0022/G           | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits | 09/01/2019   | n/a        |                 |                                   |
| N/0021              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                         | 15/11/2018   | 10/12/2019 | PL              |                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0019/G         | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   | 19/10/2018   | n/a        |                        |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------|
| T/0018              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                          | 30/08/2018   | 20/09/2018 | SmPC, Labelling and PL |                                   |
| IB/0017             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                       | 20/09/2018   | n/a        |                        |                                   |
| PSUSA/10523 /201802 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                                                                                                                                     | 06/09/2018   | n/a        |                        | PRAC Recommendation - maintenance |
| PSUSA/10523 /201708 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                                                                                                                                     | 08/03/2018   | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0015/G           | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g.                                                                                                                                                                                                                                                                                                          | 14/12/2017   | 20/09/2018 | SmPC, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

|                     | tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes                                                                                                                                                                                                                             |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0014             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                      | 05/12/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0012             | B.I.b.z - Change in control of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 04/10/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| PSUSA/10523 /201702 | Periodic Safety Update EU Single assessment - reslizumab                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 28/09/2017 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0005/G           | This was an application for a group of variations. Update of section 4.2 of the SmPC in order to include a revised dosing regimen as a result of the new 25mg vial presentation in section 2. Consequential B.II.e.5c variation to change the pack size of the finished product and update sections 6.5 and 6.6 of the SmPC. The Annex II, Package Leaflet, Labelling and Risk Management Plan v. 2.3 are updated accordingly. B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of | 23/03/2017 | 28/04/2017 | SmPC, Annex II, Labelling and PL | The Marketing Authorisation Holder has introduced a 25 mg presentation (2.5 ml fill/10 mg/mL). This presentation of reslizumab supports a vial based dosing regimen. CINQAERO is given as intravenous infusion once every four weeks. The recommended dose is based on patient body weight and should only be adjusted for significant changes in body weight.For patients below 35 kg or above 199 kg: the recommended dose is 3 mg/kg body weight. The volume (in mL) required from the vial(s) should be calculated as follows: 0.3 x patient body weight (in kg). For patients between 35 kg and 199 kg: the recommended dose is achieved using the vial based dosing scheme (please refer to Table 1 in section 4.2 of the SmPC. |

<div style=\"page-break-after: always\"></div>

|           | sterile multidose (or single-dose, partial use) parenteral medicinal products, including biological/immunological medicinal products C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                          |            |     |           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IB/0009/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other | 11/04/2017 | n/a | variation |
| IAIN/0010 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                              | 07/04/2017 | n/a |           |
| IB/0008   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                            | 07/03/2017 | n/a |           |
| IB/0007   | B.II.b.4.z - Change in the batch size (including batch                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 01/02/2017 | n/a |           |

<div style=\"page-break-after: always\"></div>

|             | size ranges) of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     |                     |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------|
| IB/0004     | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                  | 05/12/2016 | n/a |                     |
| IB/0006/G   | This was an application for a group of variations. B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition test and limits                                                                                                                                                        | 30/11/2016 | n/a | of a new in-process |
| IA/0003     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                           | 27/10/2016 | n/a |                     |
| IAIN/0001/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - control/testing | 20/09/2016 | n/a | Not including batch |